{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:43:08Z","timestamp":1784547788499,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10072-025-08194-8","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T23:19:11Z","timestamp":1745363951000},"page":"3491-3494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MOG antibody-positive patients meeting diagnostic criteria for MS: is it MOGAD with an MS-like phenotype or true MS?"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9938-5355","authenticated-orcid":false,"given":"Hung Youl","family":"Seok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"3","key":"8194_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, Ramanathan S, Waters P, Tenembaum S, Graves JS et al (2023) Diagnosis of Myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol 22(3):268\u2013282. https:\/\/doi.org\/10.1016\/S1474-4422(22)00431-8","journal-title":"Lancet Neurol"},{"issue":"9","key":"8194_CR2","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2023-333227","volume":"95","author":"AG Filippatou","year":"2024","unstructured":"Filippatou AG, Said Y, Chen H, Vasileiou ES, Ahmadi G, Sotirchos ES (2024) Validation of the international MOGAD panel proposed criteria: a single-centre US study. J Neurol Neurosurg Psychiatry 95(9):870\u2013873. https:\/\/doi.org\/10.1136\/jnnp-2023-333227","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"8194_CR3","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.1007\/s00415-024-12438-6","volume":"271","author":"A Rechtman","year":"2024","unstructured":"Rechtman A, Freidman-Korn T, Zveik O, Shweiki L, Hoichman G, Vaknin-Dembinsky A (2024) Assessing the applicability of the 2023 international MOGAD panel criteria in real-world clinical settings. J Neurol 271(8):5102\u20135108. https:\/\/doi.org\/10.1007\/s00415-024-12438-6","journal-title":"J Neurol"},{"issue":"2","key":"8194_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ana.26859","volume":"95","author":"S Kim","year":"2024","unstructured":"Kim S, Eun MY, Lee JJ, Seok HY (2024) Myelin oligodendrocyte glycoprotein Antibody-Positive patients meeting the 2017 McDonald criteria for multiple sclerosis: challenges in diagnosis and treatment decisions. Ann Neurol 95(2):415. https:\/\/doi.org\/10.1002\/ana.26859","journal-title":"Ann Neurol"},{"issue":"12","key":"8194_CR5","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jamaneurol.2023.3956","volume":"80","author":"P Lipps","year":"2023","unstructured":"Lipps P, Ayroza Galvao Ribeiro Gomes AB, Kulsvehagen L, Mutke MA, Kuhle J, Papadopoulou A, Probstel AK (2023) Ongoing challenges in the diagnosis of Myelin oligodendrocyte glycoprotein Antibody-Associated disease. JAMA Neurol 80(12):1377\u20131379. https:\/\/doi.org\/10.1001\/jamaneurol.2023.3956","journal-title":"JAMA Neurol"},{"key":"8194_CR6","doi-asserted-by":"publisher","first-page":"105034","DOI":"10.1016\/j.msard.2023.105034","volume":"79","author":"E Ganelin-Cohen","year":"2023","unstructured":"Ganelin-Cohen E, Shelly S, Schiller Y, Vaknin-Dembinsky A, Shachor M, Rechtman A, Osherov M, Duvdevan N, Rozenberg A (2023) Dual positivity for anti-MOG and oligoclonal bands: unveiling unique clinical profiles and implications. Mult Scler Relat Disord 79:105034. https:\/\/doi.org\/10.1016\/j.msard.2023.105034","journal-title":"Mult Scler Relat Disord"},{"key":"8194_CR7","doi-asserted-by":"publisher","first-page":"105860","DOI":"10.1016\/j.msard.2024.105860","volume":"91","author":"DLC van Rooij","year":"2024","unstructured":"van Rooij DLC, Samijn D, Meulman DTJ (2024) Challenges in the interpretation of positive MOG antibody testing in daily MS practice. Mult Scler Relat Disord 91:105860. https:\/\/doi.org\/10.1016\/j.msard.2024.105860","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"8194_CR8","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s13760-024-02496-y","volume":"124","author":"S Kim","year":"2024","unstructured":"Kim S, Eun MY, Lee JJ, Seok HY (2024) Trigeminal involvement in MOG antibody-associated brainstem encephalitis: a distinct clinico-radiographic presentation. Acta Neurol Belg 124(4):1433\u20131438. https:\/\/doi.org\/10.1007\/s13760-024-02496-y","journal-title":"Acta Neurol Belg"},{"issue":"2","key":"8194_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"8194_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26793","author":"J Villacieros-Alvarez","year":"2023","unstructured":"Villacieros-Alvarez J, Espejo C, Arrambide G, Castillo M, Carbonell-Mirabent P, Rodriguez M, Bollo L, Castillo J, Comabella M, Galan I et al (2023) Myelin oligodendrocyte glycoprotein antibodies in adults with a first demyelinating event suggestive of multiple sclerosis. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.26793","journal-title":"Ann Neurol"},{"key":"8194_CR11","doi-asserted-by":"publisher","first-page":"671425","DOI":"10.3389\/fimmu.2021.671425","volume":"12","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Cai MT, Li EC, Fang W, Shen CH, Zhang YX (2021) Case report: Myelin oligodendrocyte glycoprotein antibody-Associated disorder masquerading as multiple sclerosis: an Under-Recognized entity?? Front Immunol 12:671425. https:\/\/doi.org\/10.3389\/fimmu.2021.671425","journal-title":"Front Immunol"},{"key":"8194_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.msard.2019.05.021","volume":"33","author":"M Breza","year":"2019","unstructured":"Breza M, Koutsis G, Tzartos JS, Velonakis G, Evangelopoulos ME, Tzanetakos D, Karagiorgou K, Angelopoulou G, Kasselimis D, Potagas C et al (2019) MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing? Mult Scler Relat Disord 33:67\u201369. https:\/\/doi.org\/10.1016\/j.msard.2019.05.021","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"8194_CR13","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1212\/NXI.0000000000000257","volume":"3","author":"M Spadaro","year":"2016","unstructured":"Spadaro M, Gerdes LA, Krumbholz M, Ertl-Wagner B, Thaler FS, Schuh E, Metz I, Blaschek A, Dick A, Bruck W et al (2016) Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3(5):e257. https:\/\/doi.org\/10.1212\/NXI.0000000000000257","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"8194_CR14","doi-asserted-by":"publisher","first-page":"6160","DOI":"10.1007\/s00415-024-12585-w","volume":"271","author":"GS Manzano","year":"2024","unstructured":"Manzano GS, Levy M, Salky R, Mateen FJ, Klawiter EC, Chitnis T, Vasileiou ES, Sotirchos ES, Gibbons E, Huda S et al (2024) Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes. J Neurol 271(9):6160\u20136171. https:\/\/doi.org\/10.1007\/s00415-024-12585-w","journal-title":"J Neurol"},{"issue":"10","key":"8194_CR15","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41582-024-01005-2","volume":"20","author":"R Geraldes","year":"2024","unstructured":"Geraldes R, Arrambide G, Banwell B, Rovira A, Cortese R, Lassmann H, Messina S, Rocca MA, Waters P, Chard D et al (2024) The influence of MOGAD on diagnosis of multiple sclerosis using MRI. Nat Rev Neurol 20(10):620\u2013635. https:\/\/doi.org\/10.1038\/s41582-024-01005-2","journal-title":"Nat Rev Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08194-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:28:39Z","timestamp":1752643719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08194-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["8194"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08194-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"10 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}